CNS Pharmaceuticals, Inc. short interest in 2022
In 2022, CNS Pharmaceuticals, Inc.'s disclosed short interest ran from 1.37% of shares outstanding on 15 Feb 2022 to 0.23% on 15 Nov 2022, a change of -1.14 percentage points. The year's high was 1.94% on 28 Feb 2022 and its low 0.19% on 31 Oct 2022, averaging 0.77% across 16 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.22 days on 30 Sep 2022. Full history: CNS Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 1.37% (15 Feb 2022)
- End of year
- 0.23% (15 Nov 2022)
- Change
- -1.14 pp
- High
- 1.94% (28 Feb 2022)
- Low
- 0.19% (31 Oct 2022)
- Average
- 0.77%
- Highest days to cover
- 1.22 (30 Sep 2022)
- SEC filings marked
- 7
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Feb 2022 | 1.37% | 1.00 | |
| 28 Feb 2022 | 1.94% | 1.00 | |
| 15 Mar 2022 | 0.73% | 1.00 | 10-K filed, results (8-K) |
| 14 Apr 2022 | 1.01% | 1.00 | |
| 29 Apr 2022 | 0.91% | 1.00 | |
| 13 May 2022 | 0.73% | 1.00 | 10-Q filed |
| 31 May 2022 | 1.32% | 1.06 | results (8-K) |
| 15 Jun 2022 | 0.71% | 1.00 | |
| 30 Jun 2022 | 0.81% | 1.00 | |
| 29 Jul 2022 | 0.40% | 1.00 | |
| 15 Aug 2022 | 0.47% | 1.00 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 0.46% | 1.00 | |
| 15 Sep 2022 | 0.53% | 1.00 | |
| 30 Sep 2022 | 0.45% | 1.22 | |
| 31 Oct 2022 | 0.19% | 1.00 | |
| 15 Nov 2022 | 0.23% | 1.00 | 10-Q filed |
See also: CNS Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.